Xenon Pharmaceuticals Inc. (NASDAQ:XENE)’s Basic Consolidated EPS Came In At $-1.1029

0

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) posted annual consolidated EPS of $-1.1029 for the period ended 2015-12-31. But basic consolidated EPS for the quarter period ended 2015-12-31 came in at $-1.1029.

Basic EPS from continuing operations

The company’s basic EPS from continuing operations for the annual period ended 2015-12-31 came in at $-1.1029 while basic EPS from continuing operations for the three-month period to 2015-12-31 was$-1.1029.

EPS contribution from parent

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) received $-1.1029 basic EPS contribution from its parent company in the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, the parent company contributed EPS of $-1.1029.

Basic net EPS

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) posted basic net EPS of $-1.1 for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, the company posted basic net EPS of $-1.1.

Consolidated diluted EPS

The company’s consolidated diluted EPS for the period ended 2015-12-31 was $-1.1029 while consolidated diluted EPS was $-1.1029 for the quarter ended 2015-12-31.

Basic diluted EPS

Basic diluted EPS from continuing operation for the annual period ended 2015-12-31 was $-1.1029. As for the quarter, diluted EPS from continuing operations for the three-month ended 2015-12-31 stood at $-1.1029.

Net diluted EPS

Net diluted EPS was $-1.1 for the annual period ended 2015-12-31. But net diluted EPS for the quarterly period ended 2015-12-31 stood at $-1.1.

Diluted EPS from parent

From the parent company, Xenon Pharmaceuticals Inc. (NASDAQ:XENE) received diluted EPS of $-1.1029

For the annual period ended 2015-12-31, diluted EPS from Xenon Pharmaceuticals Inc. (NASDAQ:XENE)’s parent company was$-1.1029. But for the quarter period ended 2015-12-31, diluted EPS contribution from the parent company was $-1.1029.

Xenon Pharmaceuticals Inc. (NASDAQ:XENE)’s net basic EPS for the annual period ended 2015-12-31 was $-1.1 and for the quarter period ended 2015-12-31 it was $-1.1.

For the annual period ended 2015-12-31, the company had average basic shares outstanding of 14.282 while basic shares outstanding were 14.282 for the quarter period ended 2015-12-31.

The company’s diluted shares outstanding was 14.282 for the annual period ended 2015-12-31 is 14.282. That compared with 14.282 diluted shares outstanding for the quarter period ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 6 times, 1 visits today)